Partnering With Patients in the Treatment of Psoriatic Arthritis

In this video module, 2 patients join rheumatologist Jonathan Scott Coblyn, MD, to share their perceptions and experience with psoriatic arthritis while Dr. Coblyn provides expert commentary with an emphasis on patient engagement in the management of psoriatic arthritis.
Jonathan Scott Coblyn, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Released: March 15, 2017 Expiration: June 14, 2018

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Implement screening procedures to improve early detection and timely diagnosis of PsA in patients with psoriasis
  • Incorporate patient perceptions and preferences in developing comprehensive treatment plans for PsA
  • Apply a multidisciplinary approach to the management of common PsA-associated comorbidities, including depression

Information on this Educational Activity

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Jonathan Scott Coblyn, MD

Associate Professor of Medicine
Department of Medicine
Harvard Medical School
Clinical Director of Rheumatology
Division of Rheumatology
Department of Medicine
Brigham and Women's Hospital
Boston, Massachusetts

Jonathan Scott Coblyn, MD, has disclosed that he has received consulting fees from CVS Pharmacy.

Staff

Megan K. Murphy, PhD

Associate Scientific Director

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.
Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no real or apparent conflicts of interest to report.

Patient Karen F has no real or apparent conflicts of interest to report.

Patient Patricia V has no real or apparent conflicts of interest to report.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for rheumatologists, dermatologists, and other healthcare professionals caring for patients with psoriatic arthritis.

Goal

The goal of this activity is to improve physicians’ competence in understanding the patient’s perception of their disease and increasing the patient’s involvement in treatment decisions in order to improve disease management and quality of life for patients with psoriatic arthritis.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Clinical Care Options, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 15, 2017, through June 14, 2018:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Despite demonstration of comparable efficacy and safety between biosimilars and their originators, some patients avoid this treatment switch. Here’s my take on steps to assuage unfounded patient fears.

Jonathan Kay, MD Released: February 13, 2018

Watch our recent quiz game on biosimilars in rheumatologic conditions.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: November 28, 2017 Expiration: November 27, 2018

In this downloadable slideset, Jonathan Kay, MD, explores key concepts including immunogenicity, switching, and interchangeability of biosimilars.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Released: November 21, 2017

In this downloadable slideset, Stanley B. Cohen, MD, reviews the regulatory pathway and development of biosimilars.

Stanley B. Cohen, MD Jonathan Kay, MD Kenneth G. Saag, MD, MSc Released: November 21, 2017
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an educational grant from
Pfizer Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?